PAVmed

PAVM on Nasdaq. Market value $21m.

Watch this stockFree. We tell you when something changes.

Should I look at this?

Look carefully before going further

Why it could be worth it

Nothing stands out yet.

Read the warning sign in its own filings

This is not advice.

Compare with another stock

Who owns it

1 long-term investor we follow owns it, unchanged from 1 last quarter. 20 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

10 investors own more than 5%.

  • Dana Carrera
    Passive investor
    at least 15.3%+1.0 pts
    (filed with 1 related holder)
    Since 27 March 2026
  • Two Seas Capital LP
    Passive investor
    at least 10.0%
    (filed with 2 related holders)
    Since 31 March 2026
  • Ayrton Capital LLC
    Passive investor
    at least 10.0%+0.1 pts
    (filed with 2 related holders)
    Since 31 March 2026
  • Scopia Holdings LLC
    Passive investor
    at least 9.9%
    (filed with 1 related holder)
    Since 27 March 2026
  • First Manhattan Co.
    Passive investor
    at least 9.6%+5.3 pts
    (filed with 2 related holders)
    Since 31 March 2026
  • NAGELBERG DAVID S
    Passive investor
    at least 8.8%+0.2 pts
    (filed with 1 related holder)
    Since 30 June 2026
  • Kallman Craig
    Passive investor
    at least 6.0%
    (filed with 1 related holder)
    Since 27 March 2026
  • 5.8%
    Since 1 July 2025
  • Dols Scott V.
    Passive investor
    5.4%
    Since 27 March 2026
  • Aklog Lishan
    Insider or founder
    5.1%
    Since 2 April 2026
    What they said

    Dr. Aklog acquired beneficial ownership of the shares of Common Stock described in this Schedule 13D for investment purposes. Dr. Aklog may from time to time acquire beneficial ownership of additional securities for investment purposes, or dispose of securities, in the open…

    Read the filing

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

No insider bought or sold on the open market in the last 12 months.

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

1 serious warning sign in PAVmed’s filings.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 27 Mar 2026, plus the 10-Q filed 13 Aug 2026 and 5 later 8-Ks.

  • Doubt it can keep going

    Serious

    The company or its auditor warned it may not have enough money to last the next year.

    “These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying unaudited condensed consolidated financial statements are issued.”
    Show the full paragraph
    The Company’s ability to continue operations 12 months beyond the issuance of the financial statements, will depend upon its ability to control its operating costs within the limits of the amounts collected from its management service contracts with its non-consolidated subsidiaries, to substantially increase its revenues from the Veris Cancer Care platform, and to raise additional capital through various potential sources including equity or debt financings, the exercise of outstanding warrants by the holders thereof or refinancing or restructuring existing debt obligations. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying unaudited condensed consolidated financial statements are issued.

    From the 10-Q filed 13 August 2026, Part I, Item 1. Financial Statements. Read it in the filing

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.